Sustained ventricular tachycardia occurring during propafenone therapy.
The arrhythmogenic action of antiarrhythmic agents, especially the class I antiarrhythmic drugs, is well known. However till now only few such side effects were reported for propafenone in comparison with other class I antiarrhythmic drugs. We report a case of asymptomatic monomorphic ventricular tachycardia occurring during propafenone therapy with normal plasma level. Stopping this drug was quickly followed by recovery of sinus rhythm.
D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D004562:Electrocardiography; D006352:Heart Ventricles; D006801:Humans; D008297:Male; D008875:Middle Aged; D011405:Propafenone / Q000009:adverse effects*; D013610:Tachycardia / Q000139:chemically induced* / Q000503:physiopathology
D011405:Propafenone